H-D-Dab(Boc)-OMe*HCl

H-D-Dab(Boc)-OMe*HCl is a protected D-amino acid derivative featuring a Boc-protected 2,4-diaminobutyric acid (Dab) core and a methyl ester hydrochloride salt, combining a defined stereogenic D-configuration with orthogonally protected and reactive nitrogen functionality. The Boc carbamate masks one amino group to control chemoselective peptide coupling, while the remaining Dab amine can be managed through salt formation, selective deprotection, or further protection depending on the target sequence. The methyl ester provides a C-terminal handle for controlled amidation or transesterification during peptide building block preparation, and the hydrochloride counterion supports handling and downstream coupling chemistry. The compound's protected/ion-paired structure and chiral center make it suitable as a chiral amino acid intermediate for peptide synthesis, medicinal chemistry scaffolds, and stereochemically defined side-chain functionalization.

1. Peptide Synthesis

H-D-Dab(Boc)-OMe*HCl is employed in peptide synthesis workflows where a D-configured Dab residue is required as a stereodefined building block. The Boc-protected amino group supports controlled activation and coupling to form amide bonds without prematurely reacting the side-chain amine, while the methyl ester enables C-terminal conversion to amides under standard peptide coupling conditions. Hydrochloride salt formation can influence solubility and the timing of deprotection steps, enabling chemoselective sequence assembly for D-amino acid-containing peptides. Downstream, the resulting peptide intermediates can be carried into fragment coupling, solid-phase or solution-phase assembly, and subsequent side-chain derivatization to generate stereochemically constrained analogs for peptide science.

2. Protected Amino Acids

H-D-Dab(Boc)-OMe*HCl functions as a protected amino acid intermediate designed for orthogonal protection strategies in protected amino acid synthesis. The Boc carbamate provides a removable protecting group for one Dab nitrogen, supporting stepwise deprotection to expose the remaining amine for selective functionalization or for incorporation into longer sequences. The methyl ester group serves as a protected C-terminal functionality that can be transformed into carboxamide or further elaborated through ester-to-amide chemistry, aligning with common protecting-group logic in amino acid derivative manufacturing routes. The compound's stereochemical definition at the D-center supports consistent stereochemical outcomes in downstream peptide building block preparation and chiral intermediate supply.

3. Bioconjugation Chemistry

H-D-Dab(Boc)-OMe*HCl can be applied in bioconjugation chemistry when D-amino acid residues are used to modulate stability, protease resistance, or conformational preferences of conjugates. The Boc-protected Dab scaffold provides a controlled entry point to generate reactive amine-containing intermediates after selective deprotection, enabling attachment handles for linker installation, amide bond formation, or nucleophile-driven conjugation. The methyl ester can be converted to an amide-bearing conjugation intermediate, supporting coupling to activated carboxylates or derivatized biomolecule fragments. Resulting conjugation-ready Dab derivatives can be used to construct labeled peptides, affinity reagents, or biomolecule-modifying linkers that retain defined stereochemistry from the chiral amino acid precursor.

4. Peptidomimetics And SAR

H-D-Dab(Boc)-OMe*HCl supports peptidomimetic construction for structure-activity relationship studies where incorporation of a D-Dab motif helps tune backbone geometry and side-chain presentation. The protected side-chain amine and the C-terminal methyl ester enable systematic derivatization into amide-linked analogs, allowing medicinal chemistry teams to explore how Dab spacing and stereochemistry affect binding or recognition in SAR campaigns. Boc protection supports iterative synthesis of analog series by controlling which nitrogen participates in coupling at each stage, while the D-configuration provides a consistent stereochemical variable across analogs. Downstream derivatives generated from this chiral amino acid intermediate can be advanced into library synthesis, fragment elaboration, and comparative scaffold mapping within applied peptide chemistry programs.

5. Pharmaceutical Manufacturing

H-D-Dab(Boc)-OMe*HCl is suitable for pharmaceutical manufacturing contexts involving the preparation of stereochemically defined peptide intermediates and chiral fine chemicals. The Boc-protected amino functionality supports reproducible peptide coupling steps by limiting undesired side reactions, while the methyl ester provides a defined C-terminal protected group that can be converted into amide-containing intermediates used in downstream process sequences. Hydrochloride salt handling can be leveraged to control physical properties such as solubility during intermediate preparation, supporting scalable synthesis planning for protected amino acid derivatives. Resulting Dab-containing intermediates can be incorporated into manufacturing routes that produce D-amino acid-containing peptides, peptidomimetic fragments, or process-ready building blocks for further chemical elaboration.

1. C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients

2. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

3. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis